Literature DB >> 28230293

Influence of complex childhood diseases on variation in growth and skeletal development.

Babette S Zemel1,2.   

Abstract

The study of human growth and skeletal development by human biologists is framed by the larger theoretical concerns regarding the underpinnings of population variation and human evolution. This unique perspective is directly relevant to the assessment of child health and well-being at the individual and group level, as well as the construction of growth charts. Environmental, behavioral (nutrition and physical activity), and disease-related factors can prevent attainment of full genetic potential for growth. Undernutrition is most often the cause of growth faltering and poor skeletal development. Disease related factors, such as malabsorption, inflammation, and immobility also have profound effects. These effects will be illustrated with examples from diseases such as cystic fibrosis, inflammatory bowel disease, and Down syndrome. The need for separate growth charts for children with genetic disorders is often controversial because of potential medical and/or nutritional complications associated with some disorders. Children with Alagille syndrome and Down syndrome will be used to illustrate the advantages and limitations of syndrome-specific charts. This overview of health and disease effects on growth and skeletal development provides insights into the plasticity of human growth and its sensitivity to overall health and well-being.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28230293     DOI: 10.1002/ajhb.22985

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  3 in total

Review 1.  What is normal, healthy growth? Global health, human biology, and parental perspectives.

Authors:  Amanda L Thompson
Journal:  Am J Hum Biol       Date:  2021-03-24       Impact factor: 2.947

2.  Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies.

Authors:  Li Min; Wang Chunyan; Rong Biaoxue
Journal:  BMC Pediatr       Date:  2020-03-02       Impact factor: 2.125

3.  CYP11B1 variants influence skeletal maturation via alternative splicing.

Authors:  Olja Grgic; Matthew R Gazzara; Alessandra Chesi; Yoseph Barash; Struan F A Grant; Fernando Rivadeneira; Carolina Medina-Gomez; Diana L Cousminer; Jonathan A Mitchell; Vid Prijatelj; Jard de Vries; Enisa Shevroja; Shana E McCormack; Heidi J Kalkwarf; Joan M Lappe; Vicente Gilsanz; Sharon E Oberfield; John A Shepherd; Andrea Kelly; Soroosh Mahboubi; Fabio R Faucz; Richard A Feelders; Frank H de Jong; Andre G Uitterlinden; Jenny A Visser; Louis R Ghanem; Eppo B Wolvius; Leo J Hofland; Constantine A Stratakis; Babette S Zemel
Journal:  Commun Biol       Date:  2021-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.